全文获取类型
收费全文 | 775篇 |
免费 | 41篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 28篇 |
妇产科学 | 7篇 |
基础医学 | 44篇 |
口腔科学 | 26篇 |
临床医学 | 150篇 |
内科学 | 146篇 |
皮肤病学 | 2篇 |
神经病学 | 10篇 |
特种医学 | 163篇 |
外科学 | 141篇 |
综合类 | 25篇 |
预防医学 | 33篇 |
药学 | 23篇 |
肿瘤学 | 36篇 |
出版年
2023年 | 6篇 |
2022年 | 3篇 |
2021年 | 11篇 |
2020年 | 2篇 |
2019年 | 5篇 |
2018年 | 6篇 |
2017年 | 7篇 |
2016年 | 10篇 |
2015年 | 5篇 |
2014年 | 18篇 |
2013年 | 34篇 |
2012年 | 14篇 |
2011年 | 28篇 |
2010年 | 26篇 |
2009年 | 48篇 |
2008年 | 33篇 |
2007年 | 23篇 |
2006年 | 21篇 |
2005年 | 19篇 |
2004年 | 15篇 |
2003年 | 23篇 |
2002年 | 27篇 |
2001年 | 17篇 |
2000年 | 14篇 |
1999年 | 11篇 |
1998年 | 41篇 |
1997年 | 38篇 |
1996年 | 37篇 |
1995年 | 35篇 |
1994年 | 22篇 |
1993年 | 25篇 |
1992年 | 9篇 |
1991年 | 5篇 |
1990年 | 8篇 |
1989年 | 25篇 |
1988年 | 24篇 |
1987年 | 16篇 |
1986年 | 9篇 |
1985年 | 16篇 |
1984年 | 10篇 |
1983年 | 9篇 |
1982年 | 19篇 |
1981年 | 12篇 |
1980年 | 17篇 |
1979年 | 2篇 |
1978年 | 9篇 |
1977年 | 11篇 |
1976年 | 8篇 |
1975年 | 2篇 |
1972年 | 1篇 |
排序方式: 共有836条查询结果,搜索用时 0 毫秒
91.
The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia 总被引:6,自引:0,他引:6
A small subset of leukemic cells from most patients with acute myeloblastic leukemia (AML) have properties of stem cells and can be assayed by colony formation in agar or methylcellulose. Colony formation generally requires the addition of exogenous growth factors, but the exact factors required are incompletely defined. The AML colony- promoting activities of two recombinant human colony-stimulating factors (GM-CSF and G-CSF) were investigated by using blasts from 48 patients with AML. In nine cases, no colonies formed with either CSF. In seven cases colonies formed only in response to G-CSF and in 11 cases only in response to GM-CSF. In 21 cases colonies formed in response to either GM-CSF or G-CSF, and in 12 of these cases there was an additive effect between the two CSFs in determining maximum colony size. For cases responding to both GM- and G-CSF, the total number of colonies formed in response to the combination of both CSFs was almost always less than additive compared with the number of colonies formed in response to the individual CSFs. Further, the AML-CFU responding to either GM-CSF or G-CSF could not be distinguished by surface markers or by the cytochemical staining pattern of the colonies. These results suggest that there is considerable overlap between the GM-CSF- and G- CSF-responsive AML-CFU subpopulations in most cases. For five of seven cases, the combination of GM-CSF and G-CSF could replace a leukocyte feeder layer in providing maximum growth stimulation. These results indicate that GM-CSF and G-CSF are active growth factors for AML cells and are frequently additive in promoting maximum colony size. 相似文献
92.
93.
A clinical study comparing digital radiography and near‐infrared transillumination in caries detection 下载免费PDF全文
94.
95.
96.
97.
Transient leukemoid proliferation of the cytogenetically unbalanced +21 cell line of a constitutional mosaic boy 总被引:1,自引:0,他引:1
A newborn without any signs of Down's syndrome was found to have an acute proliferation that remitted without drug therapy. Chromosomal analysis of blood, bone marrow, and skin cells revealed that the child was a constitutional mosaic with normal cells and a low number of cells in which one no. 21 chromosome was replaced by a probably isochromosome for the no. 21 long arm: 46,XY/46,XY,i(21q). The abnormal cell line of the mosaic appeared to be selectively involved in this proliferation. 相似文献
98.
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors 总被引:3,自引:3,他引:3
Anderson JE; Appelbaum FR; Schoch G; Gooley T; Anasetti C; Bensinger WI; Bryant E; Buckner CD; Chauncey TR; Clift RA; Doney K; Flowers M; Hansen JA; Martin PJ; Matthews DC; Sanders JE; Shulman H; Sullivan KM; Witherspoon RP; Storb R 《Blood》1996,87(1):51-58
From 1990 to 1993 we performed a prospective study of busulfan (16 mg/kg) and cyclophosphamide (120 mg/kg) in 30 patients with refractory anemia (RA) undergoing related (n = 17) or unrelated (n = 13) donor marrow transplantation. Nineteen patients survive disease free (63% 3- year actuarial disease-free survival [DFS]) and no patient relapsed. These results were compared to those of 38 historical controls with RA treated with cyclophosphamide and total body irradiation, of whom 22 are disease-free survivors and 1 relapsed. After correcting for significant variables between the two treatment groups, we found no statistically significant difference in outcome based on preparative regimen. Combining data from these 68 patients plus 2 additional patients with RA treated before 1993 with busulfan and cyclophosphamide, we identified four variables independently associated with improved survival: younger age, shorter disease duration, lower neutrophil count pretransplant, and lower hematocrit pretransplant. We also found that 15 patients 40 to 55 years of age had a 46% 3-year actuarial DFS and 26 patients receiving unrelated or mismatched related donor marrow had a 50% 3-year actuarial DFS. We conclude that there does not appear to be any significant difference in outcome based on preparative regimen in this patient population. In addition, allogeneic bone marrow transplantation may be a reasonable approach to therapy of RA early after diagnosis. However, whether early intervention with transplantation prolongs survival over that expected without transplantation cannot be ascertained with certainty from available data. 相似文献
99.
High levels of committed erythroid and granulocytic/monocytic progenitor cells have been demonstrated in fresh blood obtained at fetoscopy. The fetal progenitor cells were more sensitive to appropriate stimuli (erythropoietin and colony-stimulating factor) than adult progenitor cells grown under the same conditions, and this was shown to be due to intrinsic differences in the progenitor cells at the different developmental stages. 相似文献
100.